Rohan Palekar is the founder of 89bio. 89bio has raised $60M in total funding. Latest round: Series A. Based in San Francisco, California.
Rohan Palekar is the CEO of 89bio, a company focused on liver and metabolic disorders. He previously helmed CNS-focused Avanir Pharmaceuticals until 2017. Under his leadership, 89bio raised a $60 million Series A financing to advance small molecules and biologics, including an FGF21 analog for nonalcoholic steatohepatitis (NASH).
Full founder directory · Investor directory · Company funding database · Fundraising library